Related Experiment Video

Updated: Mar 19, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.7K

Issues in pediatric vaccine-preventable diseases in low- to middle-income countries

Ghassan Dbaibo1, Vladimir Tatochenko2, Peter Wutzler3

  • 1a Center for Infectious Diseases Research, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center , Riad El Solh , Beirut , Lebanon.

Human Vaccines & Immunotherapeutics
|June 21, 2016
PubMed

Insights

Developing nations face significant challenges in combating pediatric vaccine-preventable diseases due to resource constraints. Experts convened to discuss and recommend strategies for overcoming barriers to pediatric vaccination programs.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • Developing nations bear the highest burden of pediatric vaccine-preventable diseases.
  • Resource limitations hinder disease diagnosis, surveillance, and vaccination program implementation.

Purpose of the Study:

  • To assess the status of 8 pediatric vaccine-preventable diseases in represented regions.
  • To identify and discuss obstacles to pediatric vaccine implementation.
  • To gather expert recommendations for overcoming these barriers.

Main Methods:

  • A Working Group Meeting was convened in Casablanca in November 2012.
  • Experts from Europe, Russia, CIS, Middle East, Africa, and South East Asia participated.
  • Discussions focused on region-specific needs and barriers to vaccine uptake.

Main Results:

  • The meeting highlighted the significant challenges in pediatric vaccination programs in developing countries.
  • Various region-specific barriers to vaccine implementation and uptake were identified.
  • Expert opinions and recommendations for improving pediatric vaccine coverage were formulated.

Conclusions:

  • Addressing resource constraints is critical for reducing the burden of pediatric vaccine-preventable diseases.
  • Collaborative efforts and tailored strategies are needed to overcome implementation obstacles.
  • Enhanced pediatric vaccination programs are essential for global child health.

Keywords:
Pediatric vaccinesbarriersdeveloping countriesvaccine implementationvaccine-preventable disease

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

17.4K
Author Spotlight: A Cost-Effective Genomic Workflow for Advancing Rabies Control in Resource-Limited Settings10:26

Author Spotlight: A Cost-Effective Genomic Workflow for Advancing Rabies Control in Resource-Limited Settings

Published on: August 18, 2023

6.6K

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Vaccinations01:51

Vaccinations

Overview
53.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
426
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
25
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K